Cimzia (certolizumab pegol) - Astellas, UCB
tesnatilimab (JNJ-64304500) - J&J
Humira (adalimumab) - AbbVie
Tremfya (guselkumab) - J&J
andecaliximab (GS-5745) - āshibio
Omvoh (mirikizumab-mrkz) - Eli Lilly
tofacitinib - Generic mfg.
onercept (r-hTBP) - EMD Serono
Jyseleca (filgotinib) - Gilead
Cyltezo (adalimumab-adbm) - Boehringer Ingelheim
Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim
Rinvoq (upadacitinib) - AbbVie
Tysabri (natalizumab) - Biogen, Royalty
etrolizumab (RG7413) - Roche
Entyvio (vedolizumab) - Takeda
Inflectra (infliximab-dyyb) - Alvogen, Celltrion, Mundipharma, Egis, Nippon Kayaku, Pfizer
Enbrel (etanercept) - Pfizer, Amgen
apilimod (STA-5326) - Madrigal Pharma
http://www.ncbi.nlm.nih.gov/pubmed/42333672
 
Alireza Sherafat; Anthony K Akobeng; Assem Elleithy; Fareed Alqusous; Gordon William Moran; Masitara Masitara; Morris Gordon; Muhammad Ibrahim Khan; Rose Cherayath; Sanjana Phlananthachai; Suzanne C Freeman; Vassiliki Sinopoulou
 
Jun 24, 2026
 
Prev Next